Analysis of galectin-3 levels as a source of coronary heart disease risk during periodontitis
- PMID: 33641161
- DOI: 10.1111/jre.12860
Analysis of galectin-3 levels as a source of coronary heart disease risk during periodontitis
Abstract
Background and objective: Different evidence has shown that Galectins have a key role as modulators of cell surface functions and signaling in a wide range of inflammatory diseases during their preclinical stages. The aim of this study was to analyze the association and impact of periodontitis and coronary heart disease (CHD) on salivary and serum Galectin-3 in patients with periodontitis and CHD.
Materials and methods: For the present study, healthy controls (n = 38), periodontitis (n = 40), CHD (n = 39), and a combination of periodontitis +CHD (n = 38) patients were enrolled and analyzed. In each patient, demographic characteristics and a full-mouth clinical periodontal examination were achieved. Moreover, serum and salivary samples were collected to assess Galectin-3 and Endothelin-1 (ET-1) levels. The Jonckheere-Terpstra p-trend and Spearman's correlation tests as well as uni- and linear regression analyses were used to analyze the study data.
Results: Patients with periodontitis (serum, p = .003; saliva, p < .001) and periodontitis + CHD groups (serum p = .004; saliva, p < .001) had higher median serum and salivary concentrations of Galectin-3 in comparison with CHD and healthy controls. Serum (p = .006) and salivary (p = .009) Galectin-3 levels were significantly correlated with serum ET-1. The multivariate regression analysis highlighted that periodontitis (p = .047) was the significant predictor of serum Galectin-3 levels while ET-1 (p = .028) was the significant predictor of salivary Galectin-3 levels.
Conclusion: The results showed that patients with periodontitis and periodontitis + CHD presented significant higher serum and salivary Galectin-3 levels in comparison with CHD patients and healthy subjects. Periodontitis and ET-1 were the significant predictors of serum and salivary Galectin-3 levels, respectively.
Keywords: c-reactive protein; clinical trial; coronary heart disease; endothelin-1; galectin-3; periodontitis.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Analysis of Endothelin-1 Concentrations in Individuals with Periodontitis.Sci Rep. 2020 Feb 3;10(1):1652. doi: 10.1038/s41598-020-58585-4. Sci Rep. 2020. PMID: 32015361 Free PMC article.
-
Expression of Salivary and Serum Malondialdehyde and Lipid Profile of Patients with Periodontitis and Coronary Heart Disease.Int J Mol Sci. 2019 Dec 1;20(23):6061. doi: 10.3390/ijms20236061. Int J Mol Sci. 2019. PMID: 31805680 Free PMC article. Clinical Trial.
-
Independent impact of periodontitis and cardiovascular disease on elevated soluble urokinase-type plasminogen activator receptor (suPAR) levels.J Periodontol. 2021 Jun;92(6):896-906. doi: 10.1002/JPER.20-0242. Epub 2020 Nov 6. J Periodontol. 2021. PMID: 33091149
-
Periodontitis: a risk factor for coronary heart disease?Ann Periodontol. 1998 Jul;3(1):127-41. doi: 10.1902/annals.1998.3.1.127. Ann Periodontol. 1998. PMID: 9722697 Review.
-
Serum antibody response against periodontal bacteria and coronary heart disease: Systematic review and meta-analysis.J Clin Periodontol. 2021 Dec;48(12):1570-1586. doi: 10.1111/jcpe.13550. Epub 2021 Oct 1. J Clin Periodontol. 2021. PMID: 34545592 Review.
Cited by
-
Oral manifestations of patients with systemic sclerosis: a meta-analysis for case-controlled studies.BMC Oral Health. 2021 May 10;21(1):250. doi: 10.1186/s12903-021-01603-2. BMC Oral Health. 2021. PMID: 33971854 Free PMC article.
-
Monitoring Cardiovascular Problems in Heart Patients Using Machine Learning.J Healthc Eng. 2023 Feb 8;2023:9738123. doi: 10.1155/2023/9738123. eCollection 2023. J Healthc Eng. 2023. Retraction in: J Healthc Eng. 2023 Nov 29;2023:9760181. doi: 10.1155/2023/9760181 PMID: 36818386 Free PMC article. Retracted.
-
Survival Rate and Prosthetic and Sinus Complications of Zygomatic Dental Implants for the Rehabilitation of the Atrophic Edentulous Maxilla: A Systematic Review and Meta-Analysis.Biology (Basel). 2021 Jun 29;10(7):601. doi: 10.3390/biology10070601. Biology (Basel). 2021. PMID: 34209770 Free PMC article. Review.
-
Periodontal Health and Disease in the Context of Systemic Diseases.Mediators Inflamm. 2023 May 13;2023:9720947. doi: 10.1155/2023/9720947. eCollection 2023. Mediators Inflamm. 2023. PMID: 37214190 Free PMC article. Review.
-
Oral microbiota in human systematic diseases.Int J Oral Sci. 2022 Mar 2;14(1):14. doi: 10.1038/s41368-022-00163-7. Int J Oral Sci. 2022. PMID: 35236828 Free PMC article. Review.
References
REFERENCES
-
- Kassebaum NJ, Bernabe E, Dahiya M, Bhandari B, Murray CJ, Marcenes W. Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. J Dent Res. 2014;93(11):1045-1053.
-
- Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol. 2018;89(Suppl 1):S159-S172.
-
- Isola G, Polizzi A, Alibrandi A, Williams RC, Leonardi R. Independent impact of periodontitis and cardiovascular disease on elevated soluble urokinase-type plasminogen activator receptor (suPAR) levels. Journal of Periodontology. 2020. http://dx.doi.org/10.1002/jper.20-0242
-
- Aoyama N, Kobayashi N, Hanatani T, et al. Periodontal condition in Japanese coronary heart disease patients: A comparison between coronary and non-coronary heart diseases. J Periodontal Res. 2019;54(3):259-265.
-
- Isola G, Lo Giudice A, Polizzi A, Alibrandi A, Murabito P, Indelicato F. Identification of the different salivary Interleukin-6 profiles in patients with periodontitis: a cross-sectional study. Arch Oral Biol. 2021;122:104997.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials